Search

for
Search:

Learn

0 / 0 results

— no results

Research

5 / 216 results

research Improving Translational Research in Sex-Specific Effects of Comorbidities and Risk Factors in Ischemic Heart Disease and Cardioprotection: Position Paper and Recommendations of the ESC Working Group on Cellular Biology of the Heart

47 citations , May 2020 in “Cardiovascular Research”

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

research Non-Biologic Immunosuppressive Drugs for Inflammatory and Autoimmune Skin Diseases

January 2024 in “Journal der Deutschen Dermatologischen Gesellschaft”

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

research Disorders of the Skin Appendages

December 2016 in “John Wiley & Sons, Ltd eBooks”

The document concludes that proper recognition and treatment of skin appendage disorders are important for management.

research Quality of Life and Mood Status Disturbances in Cohabitants of Patients with Alopecia Areata: A Cross-Sectional Study in a Spanish Population

5 citations , December 2022 in “International Journal of Environmental Research and Public Health”

Alopecia Areata affects both patients and their cohabitants' quality of life and emotional well-being.

research Ichthyosis Follicularis, Alopecia, And Photophobia (IFAP) Syndrome

71 citations , January 2011 in “Orphanet Journal of Rare Diseases”

IFAP syndrome is a rare genetic disorder causing skin, hair, and eye issues, with limited treatment options.

View more "cardiopulmonary diseases" in research →

Community Join

1 / 1 results

community So we’re just ok with taking a research chemical now?

in Treatment 178 upvotes 4 years ago

The conversation discusses the use of RU58841, a non-FDA approved research chemical for hair loss, with mixed opinions on its safety and effectiveness. Some users are willing to try it as a last resort after other treatments like Minoxidil and Finasteride failed, while others express concerns about potential long-term side effects and lack of official research.